Your browser doesn't support javascript.
loading
Remote Zone Extracellular Volume and Left Ventricular Remodeling in Survivors of ST-Elevation Myocardial Infarction.
Carberry, Jaclyn; Carrick, David; Haig, Caroline; Rauhalammi, Samuli M; Ahmed, Nadeem; Mordi, Ify; McEntegart, Margaret; Petrie, Mark C; Eteiba, Hany; Hood, Stuart; Watkins, Stuart; Lindsay, Mitchell; Davie, Andrew; Mahrous, Ahmed; Ford, Ian; Sattar, Naveed; Welsh, Paul; Radjenovic, Aleksandra; Oldroyd, Keith G; Berry, Colin.
Afiliação
  • Carberry J; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Carrick D; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Haig C; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Rauhalammi SM; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Ahmed N; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Mordi I; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • McEntegart M; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Petrie MC; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Eteiba H; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Hood S; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Watkins S; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Lindsay M; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Davie A; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Mahrous A; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Ford I; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Sattar N; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Welsh P; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Radjenovic A; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Oldroyd KG; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
  • Berry C; From the BHF Glasgow Cardiovascular Research Centre (J.C., D.C., S.M.R., N.A., I.M., M.M., M.C.P., H.E., S.H., S.W., M.L., A.D., A.M., N.S., P.W., A.R., K.G.O., C.B.) and Robertson Centre for Biostatistics (C.H., I.F.), University of Glasgow, Glasgow, United Kingdom; and Golden Jubilee National Hosp
Hypertension ; 68(2): 385-91, 2016 08.
Article em En | MEDLINE | ID: mdl-27354423
UNLABELLED: The natural history and pathophysiological significance of tissue remodeling in the myocardial remote zone after acute ST-elevation myocardial infarction (STEMI) is incompletely understood. Extracellular volume (ECV) in myocardial regions of interest can now be measured with cardiac magnetic resonance imaging. Patients who sustained an acute STEMI were enrolled in a cohort study (BHF MR-MI [British Heart Foundation Magnetic Resonance Imaging in Acute ST-Segment Elevation Myocardial Infarction study]). Cardiac magnetic resonance was performed at 1.5 Tesla at 2 days and 6 months post STEMI. T1 modified Look-Locker inversion recovery mapping was performed before and 15 minutes after contrast (0.15 mmol/kg gadoterate meglumine) in 140 patients at 2 days post STEMI (mean age: 59 years, 76% male) and in 131 patients at 6 months post STEMI. Remote zone ECV was lower than infarct zone ECV (25.6±2.8% versus 51.4±8.9%; P<0.001). In multivariable regression, left ventricular ejection fraction was inversely associated with remote zone ECV (P<0.001), and diabetes mellitus was positively associated with remote zone ECV (P=0.010). No ST-segment resolution (P=0.034) and extent of ischemic area at risk (P<0.001) were multivariable associates of the change in remote zone ECV at 6 months (ΔECV). ΔECV was a multivariable associate of the change in left ventricular end-diastolic volume at 6 months (regression coefficient [95% confidence interval]: 1.43 (0.10-2.76); P=0.036). ΔECV is implicated in the pathophysiology of left ventricular remodeling post STEMI, but because the effect size is small, ΔECV has limited use as a clinical biomarker of remodeling. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02072850.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Volume Sistólico / Remodelação Ventricular / Espaço Extracelular / Infarto do Miocárdio com Supradesnível do Segmento ST / Miocárdio Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Volume Sistólico / Remodelação Ventricular / Espaço Extracelular / Infarto do Miocárdio com Supradesnível do Segmento ST / Miocárdio Idioma: En Ano de publicação: 2016 Tipo de documento: Article